Grants for Public and State controlled institutions of higher education - Health

This funding opportunity supports organizations conducting large-scale clinical trials focused on innovative treatments for vision disorders, ensuring effective management and oversight of the research process.

This funding opportunity provides financial support to organizations in Illinois that offer independent living services to help older individuals who are blind or visually impaired maintain their independence and quality of life.

This grant provides funding to organizations that will coordinate statewide meetings to develop strategies for engaging and connecting individuals with HIV to essential healthcare services.

Northeast Delta Dental is accepting applications for grants focused on increasing access to, and the quality of, oral health care in Maine, New Hampshire, and Vermont. Grants are available to organizations that meet specific criteria, including having nonprofit status (501(c)(3) or 501(c)(4)), not discriminating on the basis of race, sex, religion, or other protected classes, and being involved in projects that address oral health needs. Funding will support initiatives such as educational programs on oral health, preventive oral health care programs, dental clinics aiming to make care more accessible, education and continuing education of dental health professionals, and research to improve oral health.

The School-Based Health Center Planning Grant Round 2 is intended to support a one-year planning process to explore the establishment of a school-based health center within CSI, TSI, and Promise Schools, and all rural districts. ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​Periodically, funding is available for the Georgia Department of Education (GaDOE) to award to districts and schools in the form of grants. This solidifies our commitment to service and support where students have the resources and tools to succeed and be prepared for life. In an effort to streamline communication and create a consistent application process, all grant opportunities currently available and those coming soon can be accessed here. ​​​​

This funding opportunity supports innovative researchers and teams in the U.S. who propose groundbreaking projects that could significantly advance biomedical and social sciences, without the need for preliminary data.

The "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation" grant aims to provide early-stage funding for the development and testing of prototypes, diagnostic disease target assays, and research tools to improve the treatment of HLBS diseases and disorders, with the goal of advancing these projects to a stage where they can attract further development support.

This program provides funding and mentorship to early-career U.S. faculty researchers to develop innovative technologies that address national security challenges.

This Notice of Funding Opportunity Announcement (NOFO) intends to supports studies that are both necessary and sufficient to inform the planning of a Phase II-IV clinical trial within NHLBI's mission. The NHLBI expects that applications to this NOFO will describe the planned clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent trial. Furthermore, this NOFO will support research projects that are designed to provide results that will be sufficient to inform the future trial without further studies. The planned Phase II, III, or IV trial must be primarily intended to test the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention and/or treatment of heart, lung, blood, and sleep disorders. In contrast to the study start up or preparation phase of NHLBI funding opportunities for clinical trials (as described at https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/clinical-trials-optimization), the R34 mechanism is intended to provide new information that answers a scientific or operational question(s) which may be pragmatic in nature and, therefore, informs the final development of a Phase II-IV clinical trial. Regardless of the results of the R34, support of the proposed future clinical trial will require a new application.

The "Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression" grant aims to fund the development and early testing of predictive tools or biomarkers that can help determine the most effective treatment for individual patients suffering from depression.

This funding opportunity provides financial support for researchers and innovators to develop advanced technologies and platforms that improve the detection, diagnosis, and treatment of heart, lung, blood, and sleep-related health issues.

The United States Agency for International Development (USAID) is seeking applications from qualified entities for an anticipated cooperative agreement to implement the USAID/Ethiopia Health Security activity. Eligibility for this award is not restricted. The purpose of the USAID/Ethiopia Health Security Activity (HSA) is to reduce the impact of infectious disease outbreaks on morbidity and mortality through building a resilient One Health (OH) surveillance, diagnostics and workforce development capacities. The HSA will achieve this through strengthening Ethiopias capacity to detect infectious disease outbreaks early, supporting the subnational laboratory systems to diagnose resistant and zoonotic pathogens and building a OH workforce to respond to any emerging or re-emerging infectious disease outbreaks. The HSA will build on the lessons drawn from the USAID Ethiopias five years of experience in the sector including but not limited to Infectious Disease Surveillance (IDDS), Core Group Partners Project (CGPP) and Africa One Health University Network (AFROHUN). The expected outcomes will be evidence-based and will objectively be measured by the progress made in the countrys capacities to prevent, detect, and respond to emerging infectious and zoonotic diseases through a One Health approach.

The Discretionary Grants Program aims to support small-scale, project-based initiatives that explore new or different approaches within an organization's current work, aligning closely with the mission of the Maine Health Access Foundation (MeHAF). The program offers grants up to $5,000 for local or regional projects and up to $10,000 for statewide activities that significantly align with MeHAF’s objectives. Applicants must propose specific projects that either expand upon existing work or explore a particular aspect of an organization's efforts, with tangible outcomes expected within one year. These projects should contribute to expanding health access and improving health but cannot fund general operations or new/current projects without a specific focus. The application process begins with a Letter of Interest (LOI) submitted through MeHAF’s grants management system, followed by a structured conversation with program leads and a final application if advanced. Grant renewed every year. Grant annual opening/ closing deadline: program opens annual in December and stays up for 11 months until the following November.

AmeriCorps improves lives, strengthens communities, and fosters civic engagement through service and volunteering. AmeriCorps brings people together to tackle some of the countrys most pressing challenges through national service and volunteerism. AmeriCorps members and AmeriCorps Seniors volunteers serve with organizations dedicated to the improvement of communities and those serving. AmeriCorps helps make service a cornerstone of our national culture. This funding announcement is an opportunity for communities to apply for funding to engage adults ages 55 and older in tackling the communitys most pressing needs through the AmeriCorps Seniors RSVP program. This is an open competition across all states and territories.

This funding opportunity supports the development of essential research resources for organizations working on allergy, immunology, and infectious diseases, benefiting the broader scientific community.

This funding opportunity provides financial support to organizations working in Sierra Leone to improve access to HIV prevention, care, and treatment services, particularly for vulnerable populations, in order to combat the HIV/AIDS epidemic.

This funding opportunity supports innovative research projects aimed at developing new drugs and therapies for mental health, substance use, and age-related neurological disorders.

This funding opportunity provides financial support to organizations that deliver comprehensive services for individuals affected by sickle cell disease and related conditions, focusing on health equity and community engagement in designated regions of Ohio.

The "Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs)" grant aims to fund ongoing studies on chronic pancreatitis and related conditions, with a focus on understanding the risk factors for pancreatic cancer in patients with chronic pancreatitis and newly diagnosed diabetes, by supporting a consortium of clinical centers and a data management center.

This funding opportunity is designed to support non-profit organizations and partnerships that aim to improve access to primary healthcare for marginalized communities in India while reducing out-of-pocket expenses.